Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic cell proliferation and differentiation

A Spyridonidis1, R Mertelsmann, R Henschler

  • 1Department of Hematology/Oncology, Albert-Ludwigs-Universität Freiburg, Germany.

Current Opinion in Hematology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis.

European review for medical and pharmacological sciences·2022
Same author

Automatic feedback control by image processing for mixing solutions in a microfluidic device.

Biomicrofluidics·2022
Same author

Dose individualization of intravenous busulfan in pediatric patients undergoing bone marrow transplantation: impact and in vitro evaluation of infusion lag-time.

The Journal of pharmacy and pharmacology·2021
Same author

Modeling of anaerobic digestion of slaughterhouse wastes after thermal treatment using ADM1.

Journal of environmental management·2018
Same author

Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia.

Bone marrow transplantation·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Colony-stimulating factors are increasingly studied for hematopoietic cell growth in stem cell transplantation. This review examines recent findings and future directions in the field.

Area of Science:

  • Hematology
  • Cell Biology
  • Transplantation Medicine

Background:

  • Colony-stimulating factors (CSFs) are crucial regulators of hematopoiesis.
  • Their application in stimulating hematopoietic cell proliferation and differentiation in vivo is a key area of research.
  • Stem cell transplantation relies heavily on effective hematopoietic recovery.

Purpose of the Study:

  • To review recent advancements in the use of colony-stimulating factors for hematopoietic cell stimulation.
  • To explore the potential future applications of CSFs in stem cell transplantation.
  • To synthesize current research findings and project future developments.

Main Methods:

  • Literature review of recently published studies on colony-stimulating factors.
  • Analysis of experimental results concerning hematopoietic cell proliferation and differentiation.

Related Experiment Videos

  • Extrapolation of future research and clinical directions.

    • Main Results:

    • Recent studies demonstrate the efficacy of CSFs in enhancing hematopoietic cell production.
    • CSFs show promise in improving outcomes for stem cell transplantation recipients.
    • Established protocols and emerging strategies for CSF application are highlighted.

    Conclusions:

    • Colony-stimulating factors are vital for stimulating hematopoietic cell growth in vivo.
    • Continued research into CSFs will likely advance stem cell transplantation therapies.
    • Future developments will focus on optimizing CSF use for better patient outcomes.